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IMPORTANCE In type 2 diabetes mellitus (T2DM), team management using protocols with
regular feedback improves clinical outcomes, although suboptimal self-management and
psychological distress remain significant challenges.
OBJECTIVE To investigate if frequent contacts through a telephone-based peer support
program (Peer Support, Empowerment, and Remote Communication Linked by Information
Technology [PEARL]) would improve cardiometabolic risk and health outcomes by enhancing
psychological well-being and self-care in patients receiving integrated care implemented
through a web-based multicomponent quality improvement program (JADE [Joint Asia
Diabetes Evaluation]).
DESIGN, SETTING, AND PARTICIPANTS Between 2009 and 2010, 628 of 2766 Hong Kong
Chinese patients with T2DM from 3 publicly funded hospital-based diabetes centers were
randomized to the JADE + PEARL (n = 312) or JADE (n = 316) groups, with comprehensive
assessment at 0 and 12 months.
INTERVENTIONS Thirty-three motivated patients with well-controlled T2DM received 32
hours of training (four 8-hour workshops) to become peer supporters, with 10 patients
assigned to each. Peer supporters called their peers at least 12 times, guided by a checklist.
MAIN OUTCOMES AND MEASURES Changes in hemoglobin A1c (HbA1c) level (primary),
proportions of patients with attained treatment targets (HbA1c <7%; blood pressure <130/80
mm Hg; low-density lipoprotein cholesterol <2.6 mmol/L [to convert to milligrams per
deciliter, divide by 0.0256]) (secondary), and other health outcomes at month 12.
RESULTS Both groups had similar baseline characteristics (mean [SD] age, 54.7 [9.3] years;
57% men; disease duration, 9.4 [7.7] years; HbA1c level, 8.2% [1.6%]; systolic blood pressure,
136 [19] mm Hg; low-density lipoprotein cholesterol level, 2.89 [0.82] mmol/L; 17.4%
cardiovascular-renal complications; and 34.9% insulin treated). After a mean (SD) follow-up
period of 414 (55) days, 5 patients had died, 144 had at least 1 hospitalization, and 586 had
repeated comprehensive assessments. On intention-to-treat analysis, both groups had
similar reductions in HbA1c (JADE + PEARL, 0.30% [95% CI, 0.12%-0.47%], vs JADE, 0.29%
[95% CI, 0.12%-0.47%] [P = .97]) and improvements in treatment targets and
psychological-behavioral measures. In the JADE + PEARL group, 90% of patients maintained
contacts with their peer supporters, with a median of 20 calls per patient. Most of the
discussion items were related to self-management.
CONCLUSIONS AND RELEVANCE In patients with T2DM receiving integrated care, peer support
did not improve cardiometabolic risks or psychological well-being.
TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00950716
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D iabetes and its complications are preventable,although there are significant gaps in care goals.1,2Experts have recommended using a multicomponent
strategy including redesign of workflow, knowledge transfer,
information technology, and quality measures to improve
diabetes and long-term care.3,4 In a meta-analysis of quality
improvement initiatives, team restructuring, case manage-
ment, and patient education had the greatest effect size in
reducing hemoglobin A1c (HbA1c), blood pressure (BP), and
low-density lipoprotein cholesterol (LDL-C) levels.5 In clinical
trials, the use of protocols, nurses, and monitors was associ-
ated with considerably lower clinical event rates than that
reported in epidemiological surveys.6 In line with the long-
term care model,7 our group has reported the benefits of
using team management and protocols with predefined pro-
cesses and treatment targets, regular feedback, and decision
support on clinical outcomes.8-10 However, psychological
distress11 and suboptimal self-management remain signifi-
cant challenges in real-world practice.12 In a meta-analysis,
duration of contact time was the main predictor for reduced
HbA1c level,
13 although the average medical consultation time
was only 6 minutes.14 In this context, peer supporters might
fill this gap by providing support for daily management, link-
age to clinical care, and ongoing social and emotional
support.15
The publicly funded Hospital Authority of Hong Kong gov-
erns all public hospitals and clinics to provide the bulk of long-
term care. In 1995, the Hospital Authority established a terri-
tory-wide electronic Clinical Management System, which uses
International Classification of Diseases, Ninth Revision, to cap-
ture all hospital discharge diagnoses. Since 1995, we have es-
tablished a Hong Kong Diabetes Registry that includes a twice-
weekly nurse-coordinated quality improvement program using
standard protocols.16 In 2007, we developed the Joint Asia Dia-
betes Evaluation (JADE) Program to deliver integrated care by
incorporating care protocols8-10 into a web-based portal to
stratify risk with personalized reports and decision support to
promote informed decisions.17,18
By reorganizing the workflow and using the web-based
JADE (Joint Asia Diabetes Evaluation) portal to provide inte-
grated care, we aim to reduce clinical inertia and nonadher-
ence to improve cardiometabolic risk. In these patients receiv-
ing integrated care, we hypothesized that added frequent
contacts through a telephone-based peer support (PEARL [Peer
Support, Empowerment, and Remote Communication Linked
by Information Technology]) program can improve self-
management and psychological well-being to improve cardio-
metabolic risk factors (Figure 1).
Methods
This study was approved by the Joint Chinese University of
Hong Kong Hospital Authority New Territories East Cluster
Clinical Research Ethics Committee. All patients provided writ-
ten informed consent. The trial flow is shown in Figure 1. Of
3714 participants, 628 were randomized after 3086 were ex-
cluded (312 to JADE + PEARL and 316 to JADE only) (Figure 2).
The JADE Program
The study was conducted in 3 diabetes centers that provide
twice-weekly structured comprehensive assessments3 imple-
mented through the JADE portal (refer to video at http://www
.idfce-hk.org). Using these clinical and biochemical results, the
JADE portal generated 1 of 4 risk categories based on different
combinations of cardiovascular-renal complications, chronic
kidney disease (CKD) (defined as estimated glomerular filtra-
tion rate [eGFR] less than 60 mL/min/1.73m2), risk scores for
cardiovascular-renal disease,19-22 and number of risk factors (see
eAppendix in Supplement). These 4 risk categories had been
internally validated with 5-year probabilities of all events at 38%,
18%, 12%, and 5% respectively.17 The personalized report dis-
played the risk category, 5-year probabilities of individual clini-
cal event in bar charts, and trend lines of attained and recom-
mended target values of HbA1c, BP, LDL-C, and body weight.
These target values triggered reminders on medication adher-
ence, self-monitoring, weight control, diet, and physical activ-
ity for patients and periodic assessments, individualized goals,
and treatment intensification for physicians.18 All patients re-
ceived their reports 4 to 6 weeks later during a 2-hour nurse-
led group empowerment class with reinforcement on self-
care and attainment of multiple treatment targets. All patients
were followed up in their usual clinics every 3 to 4 months,
when most physicians ordered HbA1c measurement and re-
corded BP and bodyweight, in accordance with international
guidelines. However, as in most public health care institu-
tions, different physicians reviewed these patients with short
consultation time. In this project, we enhanced the care by using
a research assistant to retrieve the appointment dates, labora-
tory results, and clinic measurements from the Clinical Man-
agement System. The available data were entered into the JADE
portal to generate follow-up reports, which were mailed to the
patients with a cover letter, encouraging them to discuss their
progress with their care team as appropriate.
The “Train-the-Trainer” Program
Our diabetes nurses first invited 79 motivated patients with
HbA1c levels lower than 8% to attend a “Train-the-Trainer” pro-
gram consisting of four 8-hour workshops, each attended by
30 to 35 patients. The training program was designed by health
care professionals and behavioral scientists and run by neuro-
linguistic consultants, sports scientists, psychologists, nurses,
and physicians. The training format included tutorials, case
sharing, reflections, role playing, games, and activities with peer
supporters receiving tutorial notes and reference materials.
Throughout these sessions, they were reinforced on the prin-
ciples of communication and empathic listening and encour-
aged to share their positive experiences to assist their peers to
manage diabetes on a day-to-day basis. The peer supporters
were reminded of factors that could influence blood glucose
level, eg, diet, exercise, poor sleep, stress, changes in daily rou-
tines, body weight, medications, and concurrent illnesses, and
thus the importance of self-monitoring of blood glucose. Some
of them were active members of patient groups organized by
lay associations or diabetes centers. All participants under-
went a before and after evaluation of diabetes knowledge and
psychological-behavioral measures.
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The PEARL Program
Inclusion and Exclusion Criteria
All Chinese patients with type 2 diabetes mellitus (T2DM) aged
18 to 70 years who underwent comprehensive assessments and
expressed willingness to participate were eligible. Exclusion
criteria included illiteracy, inability to communicate in Chi-
nese, and JADE Risk Category 1 (no complication, ≤1 risk fac-
tor, and low-risk score) (see eAppendix in Supplement). Be-
cause these peer supporters had not been trained on how to
handle psychotic symptoms, thought disorders, and suicidal
ideas, patients requiring psychiatric treatment were also
excluded.
Study Design, Implementation, and Randomization
The study was funded by the American Academy for Family
Physicians Foundation, which competitively reviewed the
full proposal. Predefined primary, secondary, and other out-
come measures were included in this review. Eligible
patients were invited to participate in the program after
they received their personalized report during the group
empowerment class at the diabetes centers. None of the
peer supporters attended these sessions. After giving writ-
ten informed consent, the participants completed ad-
ditional questionnaires to assess psychological distress,
medication adherence, and self-care. The project was
administered by the office of the Asia Diabetes Foundation,
which prepared consecutively numbered, opaque, and
sealed envelopes containing computer-generated random
numbers, which were sent to each of the 3 centers in blocks
of 100, with 1:1 ratio of assignment. At the center, the enve-
lope was opened by a non–nursing staff not involved in the
study.
Figure 1. Conceptual Framework and Study Design
JADE + PEARL  Group
JADE + PEARL Group
JADE Group
Follow-up visits by physicians every 3-4 mo
• 4-Hour comprehensive assessment
• Report on individualized risk profile
and attainment of treatment targets
given to both patient and physician
• 2-Hour group education by nurses
on how to interpret reports as well
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The conceptual framework and study
design to evaluate the effects of
providing frequent support through a
telephone-based peer support
program (PEARL [Peer Support,
Empowerment, and Remote
Communication Linked by
Information Technology]) to reduce
cardiometabolic risk and
hospitalization rates by improving
psychological well-being and
self-management in patients with
type 2 diabetes mellitus receiving
integrated care implemented through
a web-based multicomponent quality
improvement program (JADE [Joint
Asia Diabetes Evaluation]) with risk
stratification, personalized reports,
regular feedback, and decision
support.
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Intervention by Peer Supporters
Of the 59 patients who completed the course, 33 agreed to be-
come peer supporters and attended an additional 3-hour brief-
ing session on the rationale, objectives, and protocol of the
study, led by the project team. Of these 33 peer supporters, 35%
were male and the mean (SD) age, disease duration, and HbA1c
level were 55.6 (11.5) years, 11.03 (6.71) years, and 7.25% (1.27%),
resepectively; 9 were treated with insulin. Among them, 29 had
secondary school or higher education, 7 of whom had ter-
tiary education. The majority of them were retired managers
or skilled or nonmanual workers. During this briefing ses-
sion, they were reminded of their non–health care profes-
sional status and to advise their peers to seek medical advice
for uncertain issues. They were asked to keep sensitive infor-
mation confidential for sharing only with the medical team.
All peer supporters were given a booklet on resources (eg, web-
sites and telephone numbers of community centers, lay asso-
ciations, and hospital diabetes centers and titles of self-help
books) and a 3-monthly checklist to document the discussion
items (diet, exercise, self-monitoring of blood glucose, sick day
management, foot care, emotional support, resources for in-
formation, and clinical care), duration of each call, and rel-
evant remarks. The peer supporters were asked to mail the
completed checklist to the Asia Diabetes Foundation project
coordinator, who entered the data and sent new checklists and
stipend to the peer supporters. The physicians, nurses, and
project coordinators met all peer supporters on 3 occasions for
a half-day meeting to facilitate experience sharing, mutual sup-
port, and problem shooting.
Introduction of Peer Supporters to Peers by Nurses
For patients assigned to the JADE + PEARL group, the
nurses put them in groups of 10 and arranged a separate
2-hour session when 2 to 3 groups of patients were intro-
duced to their assigned peer supporters, each of whom was
assigned 10 patients. None of the peer supporters were
aware of the details of the control group. During these
weekend sessions, the nurses facilitated group sharing on
self-care and stress management. After exchanging tele-
phone numbers, the peer supporters were instructed to call
their assigned peers at least 12 times—initially, biweekly
calls for 3 months, then monthly calls for 3 months, and
then 1 call every other month for 6 months, with an antici-
pated 15 minutes per call. Both peer supporters and peers
were encouraged to call one another ad lib (Figure 1). In
Hong Kong, the median monthly income was US $1800 (ap-
proximately US $10 per hour). Together with 15 minutes
of documentation, we estimated that each peer supporter
would spend 60 hours calling their assigned 10 peers.
All peer supporters were happy to volunteer but we decided
to offer them US $500 (80% of hourly rate) as a small
stipend.
Main Outcomes and Measures
The primary outcome was change in HbA1c level and the sec-
ondary outcome was the proportion of patients with attained
ABC goals (HbA1c <7.0%; BP <130/80 mm Hg; LDL-C level <2.6
mmol/L [to convert to milligrams per deciliter, divide by
0.0259]). Other outcomes included psychological-behavioral
measures using validated instruments in the Chinese lan-
guage at 12 months. The latter included EQ-5D (5-item Euro-
qol for quality of life),23 PHQ-9 (9-item Patient Health Ques-
tionnaire for depression),24 DASS-21 (21-item Depression
Anxiety Stress Scale for psychological distress),25 DES-20 (20-
item Diabetes Empowerment Scale for self-efficacy),26 and
CDDS-15 (Chinese 15-item Diabetes Distress Scale).27 We trans-
lated the SDSCA1-14 (14-item Summary for Diabetes Self-care
Activities)28 and a 4-item questionnaire29 to assess self-care
and medication adherence, respectively. We used Chinese-
validated cutoff points to define psychological distress (PHQ-9
score ≥7,30 DASS-21 score ≥17,28 and CDDS-15 score ≥4527)
(Table 1).
Figure 2. Trial Flow Diagram
3714 Participants for comprehensive
assessment
3086 Excluded
948 Did not meet inclusion criteria
2138 Refused to participate
1497 Were too busy (70%)
405 Were not willing to be contacted
by strangers (18.9%)
236 Did not want additional support (11.0%)
628 Randomized
296 Completed 1-y follow-up (94.9%) 290 Completed 1-y follow-up (91.8%)
312 JADE + PEARL 316 JADE
26 Did not complete protocol
3 Died
23 Did not have repeated assessment
16 Did not complete protocol
2 Died
14 Did not have repeated assessment
Randomization, retention, and
outcomes of 628 patients with type 2
diabetes mellitus receiving integrated
care through the JADE program
randomized to receive either peer
support (JADE + PEARL group) or no
peer support (JADE group). JADE
indicates Joint Asia Diabetes
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Table 1. Baseline Characteristics of Patients
Variable
Nonparticipants
(1 of 3 Centers)
(n = 1514)
Participants




(n = 316) P Value
Demographics
Age, mean (SD), y 55.5 (9.7) 54.7 (9.3) .07 54.5 (9.9) 54.8 (8.6) .67
Men, No. (%) 755 (49.9) 355 (56.5) .005 178 (57.1) 177 (56.0) .79
Disease duration, mean (SD), y 9.6 (7.6) 9.4 (7.7) .59 9.2 (7.8) 9.6 (7.7) .58
Employed (full-time or
part-time), No. (%)
678 (44.8) 303 (48.3) .14 145 (46.5) 158 (50.0) .32
Manual worker among those
employed, No. (%)
263 (17.5) 83 (13.2) .01 35 (23.5) 48 (30.6) .20
Education, No. (%)
<6 y 674 (44.7) 228 (36.3)
.002
109 (34.9) 119 (37.7)
.346-11 y 639 (42.3) 309 (49.2) 154 (49.4) 155 (49.1)
>11 y 196 (13.0) 91 (14.5) 49 (15.7) 42 (13.3)
Tobacco use (current or
former), No. (%)
463 (30.6) 219 (34.9) .052 104 (33.3) 115 (36.4) .39
Alcohol use (regular or
occasional), No. (%)
488 (32.2) 206 (32.9) .78 103 (33.1) 103 (32.6) .89
Complications and comorbidities,
No. (%)
Chronic kidney disease 104 (6 .9) 46 (7.4) .69 23 (7.5) 23 (7.3) .94
Retinopathy 421 (27.8) 222 (35.4) .001 116 (37.2) 106 (33.5) .34
Sensory neuropathy 76 (5.0) 40 (6.4) .21 25 (8.0) 15 (4.7) .09
All heart events 108 (7.1) 67 (10.7) .006 33 (10.6) 34 (10.8) .92
Cardiovascular-renal
complications
210 (13.9) 109 (17.4) .04 54 (17.3) 55 (17.4) .95
Risk categories, No. (%)a
Very high 210 (13.9) 109 (17.4)
<.001
54 (17.3) 55 (17.4)
.68
High 11 127 (74.4) 489 (77.9) 240 (76.9) 249 (78.8)
Medium 57 (10.4) 28 (4.5) 18 (5.8) 10 (3.2)
Low 20 (1.3) 2 (0.3) 0 2 (0.6)
Treatment for diabetes, No. (%)
Lifestyle modification only 119 (7.9) 56 (8.9)
<.001
28 (9.0) 28 (8.9)
.16
Oral drugs only 1034 (68.3) 353 (56.2) 166 (53.2) 187 (59.2)
Insulin only 102 (6.7) 38 (6.1) 25 (8.0) 13 (4.1)
Oral drugs and insulin 25 (17.1) 181 (28.8) 93 (29.7) 88 (27.9)
Treatment for other risk factors,
No. (%)
BP-lowering drugs 843 (55.7) 409 (65.1) <.001 199 (63.8) 210 (66.5) .48
ACE inhibitors 588 (38.8) 292 (46.5) .001 147 (47.1) 145 (45.9) .76
Angiotensin II receptor
blockers
89 (5.9) 55 (8.8) .02 22 (7.1) 33 (10.4) .13
Lipid-regulating drugs 631 (41.7) 278 (44.3) .27 142 (45.5) 136 (43.0) .53
Statins 554 (36.6) 249 (39.6) .18 125 (40.1) 124 (39.2) .88
Risk factor control
BMI, mean (SD) 26.1 (4.4) 26.9 (4.5) <.001 26.6 (4.3) 27.1 (4.6) .17
Systolic BP, mean (SD), mm Hg 137 (19) 136 (19) .42 136 (19) 135 (19) .70
Diastolic BP, mean (SD),
mm Hg
80 (11) 80 (11) .48 80 (10) 80 (11) .94
HbA1c, mean (SD), % 7.5 (1.4) 8.2 (1.6) <.001 8.2 (1.7) 8.2 (1.6) .89
HDL-C, mean (SD), mmol/L 1.30 (0.38) 1.21 (0.36) <.001 1.21 (0.35) 1.20 (0.36) .72
LDL-C, mean (SD), mmol/L 2.83 (0.84) 2.89 (0.82) .15 2.90 (0.81) 2.87 (0.82) .59
Total cholesterol, mean (SD),
mmol/L
4.80 (0.97) 4.87 (1.07) .20 4.86 (0.98) 4.87 (1.15) .99
Triglycerides, median (IQR),
mmol/L
1.28 (0.90-1.80) 1.40 (1.00-2.00) <.001 1.40 (1.00-2.00) 1.40 (1.00-2.00) .85
General obesity, No. (%) 478 (31.6) 245 (39.1) .001 110 (35.3) 135 (43.0) .047
(continued)
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Sample Size and Statistical Analysis
With an HbA1c level reduction of 0.5% as a surrogate marker
for long-term clinical benefits, with 1.7% standard deviation,
250 patients in each arm gave 90% power at an α level of .05
to confirm the benefits of peer support on glycemic control.
We recruited more than 600 patients, assuming a 10% attri-
tion rate. All data were analyzed by personnel not involved in
the intervention program (Y.S., Y.Z, and W.G.). We applied in-
tention-to-treat analysis to all randomized patients using SPSS
version 20.0 (SPSS Inc, an IBM company) and SAS release 9.30
(SAS Institute Inc) statistical software. All data are expressed
as mean (SD) or median (interquartile range [IQR]), as appro-
priate. For patients who defaulted reassessment at 1 year, we
retrieved their laboratory results within 3 months of the due
date from the Clinical Management System, if available. The
Pearson χ2 test, Fisher exact test, t test, Wilcoxon paired test,
Table 1. Baseline Characteristics of Patients (continued)
Variable
Nonparticipants
(1 of 3 Centers)
(n = 1514)
Participants




(n = 316) P Value
Central obesity, No. (%) 980 (64.7) 443 (71.0) .005 212 (67.9) 231 (74.0) .09
Hypertension, No. (%) 1226 (81.0) 528 (84.1) .09 257 (82.1) 271 (86.0) .18
Dyslipidemia, No. (%) 1343 (88.9) 588 (93.8) .001 289 (92.3) 299 (95.2) .13
Urinary sport ACR, median
(IQR), mg/mmol
1.5 (0.6-5.8) 2.0 (0.7-10.2) .004 2.0 (0.8-10.2) 2.0 (0.6-10.4) .52
eGFR, median (IQR),
mL/min/1.73 m2
109 (90-126) 109 (80-129) .46 110 (91-128) 106 (88-129) .53
Microalbuminuria, No. (%) 341 (23.3) 166 (26.8) .09 78 (25.5) 88 (28.1) .46
Macroalbuminuria, No. (%) 194 (13.3) 106 (17.1) .02 59 (19.3) 47 (15.0) .16
Attainment of treatment targets,
No. (%)
HbA1c <7% 626 (41.4) 143 (22.8) <.001 73 (23.4) 70 (22.2) .71
BP <130/80 mm Hg 477 (31.5) 195 (31.1) .84 94 (30.1) 101 (32.0) .62
LDL-C <2.6 mmol/L 594 (39.7) 226 (36.5) .18 118 (38.2) 108 (34.8) .39
At least 1 target 1135 (75.4) 407 (65.4) .001 204 (65.8) 203 (65.1) .85
At least 2 targets 481 (31.9) 142 (22.7) <.001 76 (24.4) 66 (21.0) .30




PHQ-9, mean (SD), score NA NA NA 4.3 (4.2) 4.1 (4.1) .47
PHQ-9 score ≥7, No. (%) NA NA NA 64 (20.5) 71 (22.6) .52
DASS-21 (negative emotions),
median (IQR), score
NA NA NA 7 (0-14) 7 (0-15) .94
DASS-21 score ≥17, No. (%) NA NA NA 58 (18.6) 66 (20.9) .48
CDDS-15 (diabetes distress),
mean (SD), score
NA NA NA 43.1 (15.0) 41.2 (14.6) .28
CDDS-15 score ≥45, No. (%) NA NA NA 133 (42.8) 127 (40.3) .53
DES-20 (self-efficacy), mean
(SD), score
NA NA NA 76.9 (8.2) 76.0 (8.1) .17
SDSCA-14 (self-care
activities), mean (SD), score
NA NA NA 48.7 (17.6) 48.6 (17.5) .99
EQ-5D index (quality of life),
mean (SD), score
NA NA NA 0.91 (0.15) 0.90 (0.19) .30
Medication adherence, No. (%)
Adherence
High NA NA NA 128 (43.1) 137 (46.3)
.36Intermediate NA NA NA 150 (50.5) 144 (48.6)
Low NA NA NA 19 (6.4) 15 (5.1)
Forgot and/or careless about
medications, No. (%)
NA NA NA 180 (58.3) 178 (57.6) .87
Abbreviations: ACE, angiotensin-converting enzyme; ACR, albumin to
creatinine ratio; BMI, body mass index (calculated as weight in kilograms
divided by height in meters squared); BP, blood pressure; CDDS-15, 15-item
Chinese Diabetes Distress Scale; DASS-21, 21-item Depression Anxiety Stress
Scale; DES-20, 20-item Diabetes Empowerment Scale; eGFR, estimated
glomerular filtration rate; EQ-5D, 5-item Euroqol; HbA1c, hemoglobin A1c;
HDL-C, high-density lipoprotein cholesterol; IQR, interquartile range; JADE,
Joint Asia Diabetes Evaluation; LDL-C, low-density lipoprotein cholesterol;
NA, no psychological assessment; PEARL, Peer Support, Empowerment, and
Remote Communication Linked by Information Technology; PHQ-9, 9-item
Patient Health Questionnaire; SDSCA-14, 14-item Summary of Diabetes Self-care
Assessment.
Conventional conversion factors: To convert cholesterol and triglycerides to
milligrams per deciliter, divide by 0.0259 and 0.0113, respectively.
a See eAppendix in Supplement for definitions of risk categories, complications,
and risk parameters and score ranges for assessment tools.
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and Mann-Whitney test were used for group comparisons, as
appropriate. For each patient, we censored the hospitaliza-
tion data at 1 year or date of reassessment. For hospitalization
data, we used zero-inflated negative binomial regression with
adjustment for age, sex, disease duration, and risk category.
P < .05 (2-tailed) was considered significant.
Results
Between 2009 and 2010, 628 of 2766 eligible patients who un-
derwent comprehensive assessment agreed to participate. The
reasons of refusal included being too busy (70.0%), not want-
ing to be contacted by strangers (18.9%), or not wanting addi-
tional support (11.0%). Participants were more likely to be men
with higher education but also with higher rates of complica-
tions, risk factors, and use of multiple medications. Using Chi-
nese-validated cutoff points, 20% to 40% of participants had
emotional distress based on several pertinent measures, and
50% admitted to being forgetful or careless about their medi-
cations (Table 1).
After a mean (SD) follow-up of 414 (55) days, 144 had at least
1 hospitalization and 31 developed cancer, cardiovascular-
renal complications, or died, with similar event rates be-
tween groups. Two patients died in the JADE + PEARL group
(1 with asthma and 1 with vocal cord leukoplakia) and 3 in the
JADE group (1 with stroke, 1 with atrial fibrillation, and 1 with
peripheral vascular disease). At 1 year, 586 had repeated as-
sessments (Figure 2). In the intention-to-treat analysis, HbA1c
level was reduced by 0.3% in both groups. Both groups had
similar proportions with improved treatment targets (1 tar-
get, 65.8%-81.0% [JADE + PEARL] vs 65.1%-81.0% [JADE]; 2 tar-
gets, 24.4%-32.5% [JADE + PEARL] vs 21.0%-37.0% [JADE]; 3
targets, 1.6%-5.6% [JADE + PEARL] vs 3.2%-6.8% [JADE]
[P < .001 within group; nonsignificant between groups]), and
10% to 20% of patients had their treatments intensified
(Table 2). Both groups also improved similarly and signifi-
cantly in most psychological-behavioral parameters includ-
ing medication adherence and self-efficacy (Table 2). During
the study period, 26% in the JADE group and 20% in the
JADE + PEARL group were hospitalized at least once, 40% of
which were due to cardiovascular-renal events. Hospitalized
Table 2. Changes in Cardiometabolic Risk Factors and Psychological-Behavioral Measures in Patients With Type












b −0.30 (−0.47 to −0.12) −0.29 (−0.47 to −0.12) .97
BP, mm Hg
Systolic −3.17 (−5.14 to −1.20) −2.72 (−4.86 to −0.59) .76
Diastolic −3.58 (−4.78 to −2.38) −3.84 (−5.04 to −2.65) .76
Body weight, kg −0.28 (−0.68 to 0.12) 0.00 (−0.48 to 0.47) .38
BMI −0.09 (−0.25 to 0.06) 0.01 (−0.18 to 0.21) .41
Waist, cm
Men 1.24 (0.50 to 1.98) 1.51 (0.78 to 2.24) .61
Women 1.44 (0.53 to 2.34) 1.05 (0.06 to 2.04) .57
Total cholesterol, mmol/L −0.24 (−0.35 to −0.13) −0.27 (−0.40 to −0.14) .73
HDL-C, mmol/L 0.08 (−0.04 to 0.11) 0.07 (−0.04 to 0.09) .67
LDL-C, mmol/L 0.29 (0.20 to 0.39) 0.26 (0.16 to 0.36) .65
Triglycerides, mmol/L −0.05 (−0.18 to 0.07) −0.25 (−0.45 to −0.04) .11
eGFR, mL/min/1.73 m2 −6.09 (−7.77 to −4.41) −4.90 (−7.33 to −2.47) .43
Urinary ACR, mg/mmol −14.74 (−24.82 to −4.66) −14.57 (−23.31 to −5.83) .98
Addition of insulin, No. (%) 24 (8.1) 33 (11.4) .18
Addition of lipid-regulating drugs,
No. (%)
41 (13.8) 55 (19.0) .09
Addition of RAS inhibitors, No. (%) 37 (12.5) 30 (10.3) .72
PHQ-9 score 0 (−0.42 to 0.41) 0.01 (−0.46 to 0.49) .96
DASS-21 score −1.47 (−2.67 to −0.27) −0.64 (−1.88 to 0.61) .34
CDDS-15 score −2.56 (−4.27 to −0.86) −2.1 (−3.84 to −0.37) .71
DES-20 score 1.35 (0.24 to 2.45) 1.24 (0.06 to 2.42) .90
SDSCA-14 score 4.09 (2.11 to 6.07) 4.56 (2.62 to 6.50) .74
EQ-5D score −0.01 (−0.28 to 0.22) 0.00 (−0.28 to 0.33) .68
Medication adherence score −0.17 (−0.30 to −0.04) −0.03 (−0.15 to 0.09) .11
Forgot and/or careless about
medications, No. (%)
87 (28.2) 78 (25.2) .41
Abbreviations: ACR, albumin to
creatinine ratio; BMI, body mass index
(calculated as weight in kilograms
divided by height in meters squared);
BP, blood pressure; CDDS-15, 15-item
Chinese Diabetes Distress Scale;
DASS-21, 21-item Depression Anxiety
Stress Scale; DES-20, 20-item
Diabetes Empowerment Scale;
eGFR, estimated glomerular filtration
rate; EQ-5D, 5-item Euroqol;
HbA1c, hemoglobin A1c; HDL-C,
high-density lipoprotein cholesterol;
JADE, Joint Asia Diabetes Evaluation;
LDL-C, low-density lipoprotein
cholesterol; PEARL, Peer Support,
Empowerment, and Remote
Communication Linked by Information
Technology; PHQ-9, 9-item Patient
Health Questionnaire;
RAS, renin-angiotensin system;
SDSCA-14, 14-item Summary of
Diabetes Self-care Assessment.
Conventional conversion factors: To
convert cholesterol and triglycerides
to milligrams per deciliter, divide by
0.0259 and 0.0113, respectively.
a Data are given as mean (95% CI)
unless otherwise specified.
b For patients who did not return for
repeated comprehensive
assessment at 1 year, HbA1c values
within 3 months of the due date for
assessment were retrieved from the
Clinical Management System.
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patients were older and had multiple complications, treat-
ments, and negative emotions. The JADE + PEARL group had
fewer rehospitalizations (≥2 admissions) than the JADE group
(5.5% vs 11.7%), mainly because of short stays of less than 10
days (16.7% vs 22.2%) (Table 3).
Post Hoc Analysis
In light of lower rehospitalization rates, mainly due to short
stays in the JADE + PEARL group and according to our con-
ceptual framework (Figure 1), we hypothesized that frequent
contacts through peer support might improve self-man-
agement and psychological distress with reduced hospitaliza-
tions. Because peer support has been reported to reduce
depressive symptoms31 and chronic disease self-manage-
ment might reduce rehospitalization rates,32 we conducted
an exploratory analysis to examine possible interactions
between peer support and emotional distress on hospitaliza-
tion rates. We stratified patients by DASS-21, CDDS-15, and
PHQ-9 scores and found associations with hospitalization
only with DASS-21. When a DASS-21 score of 17 or higher was
used as an indicator, 124 patients (19.7%) had elevated levels
of distress, who were more obese and had lower medication
adherence than those without distress. In these patients,
peer support improved DASS-21 score (mean change [95% CI],
11.93 [1.07 to 16.79] vs 5.88 [2.00 to 9.76] [P = .03]) and medi-
cation adherence score (mean change [95% CI], 0.53 [0.17 to
0.88] vs −0.06 [−0.33 to 0.22] [P = .009]). Patients with
elevated levels of distress were more likely to be hospitalized
(42 of 124 [34%]) than those without (102 of 503 [20%]). In
these patients, JADE + PEARL reduced hospitalizations with
relative risks of 0.15 (95% CI, 0.07-0.34) (P < .001) for hospi-
talization rates and 0.16 (95% CI, 0.05-0.56) (P = .004) for day
admissions relative to the PEARL group. In the nondistressed
group, peer support did not have any effect on hospitaliza-
tion rates.
Adoption and Satisfaction With the PEARL Program
Two peer supporters withdrew from the program and their
assigned patients were transferred to other peer supporters.
In the JADE + PEARL group, 279 patients (90%) maintained
contacts with their peer supporters (5227 calls in total;
median [interquartile range] calls per patient, 20 [9-24]). Diet
(17.6%), exercise (15.6%), self-monitoring of blood glucose
(15.5%), self-care (13.1%), and medication use (11.4%) were
the most popular discussion items.
Discussion
In this 1-year study, peer support did not improve cardiometa-
bolic and psychological well-being in patients with T2DM re-
ceiving integrated care. In an exploratory analysis, patients with
negative emotions appeared to benefit from additional peer
support with better treatment compliance, improved psycho-
logical health, and reduced hospitalizations. However, these
interactions were not a priori outcomes of the trial and must
be interpreted with caution.
In a 6-month study, peer support reduced HbA1c level by
0.77% compared with usual care in 300 patients with T2DM
with a mean HbA1c level of 10% at baseline.33 In another
6-month study involving 244 patients with diabetes, mean
HbA1c level decreased from 8.02% to 7.73% in the peer sup-
port group and increased from 7.93% to 8.22% in the control
group.34 In the present cohort with a mean HbA1c level of 8.2%,
integrated care reduced HbA1c level by 0.3% in both groups,
with a 50% reduction in medication nonadherence rate, and
8% to 10% of patients had their treatments intensified. These
patients also had less emotional distress with better self-
efficacy and self-care, suggesting that reorganizing care and
empowering patients with personalized information could re-
sult in clinical benefits. Adding peer support to this reorgani-
Table 3. Comparisons of Hospitalization Rates Between Patients With Type 2 Diabetes Mellitus Receiving Integrated Care Randomized to Peer























437 (51) 404 (53) 443 (62) 406 (59) 435 (49) 404 (51)
No. of hospitalization
admissions, No. (%)
0 249 (79.8) 235 (74.4) 48 (82.8) 34 (51.5) 200 (79.1) 201 (80.4)
1 46 (14.7) 44 (13.9) 8 (13.8) 19 (28.8) 38 (15.0) 25 (10.0)
2 8 (2.6) 17 (5.4) 0 5 (7.6) 8 (3.2) 12 (4.8)
≥3 9 (2.9) 20 (6.3) 2 (3.4) 8 (12.1) 7 (2.8) 12 (4.8)
Total length of stay, No. (%)
1-2 d 37 (11.9) 46 (14.6) 5 (8.6) 20 (30.3) 32 (12.6) 26 (10.4)
3-5 d 9 (2.9) 11 (3.5) 1 (1.7) 4 (6.1) 8 (3.2) 7 (2.8)
6-10 d 6 (1.9) 13 (4.1) 1 (1.7) 4 (6.1) 5 (2.0) 9 (3.6)
≥11 d 11 (3.5) 11 (3.5) 3 (5.2) 4 (6.1) 8 (3.2) 7 (2.8)
Abbreviations: DASS-21, 21-item Depression Anxiety Stress Scale; JADE, Joint Asia Diabetes Evaluation; PEARL, Peer Support, Empowerment, and Remote
Communication Linked by Information Technology.
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zation of care, however, did not further improve cardiometa-
bolic or psychological health.
It is noteworthy that hospitalization rate was lower in the
JADE + PEARL group despite lack of improvement in cardio-
metabolic risks and psychological health. In a 6-month study,
patients with multiple morbidities who received coaching on
the chronic disease self-management program had better
health behavior and health status and spent 0.8 fewer hospi-
tal nights compared with the control group.32 In another
6-month study, chronically ill patients who received a post-
discharge telephone intervention had lower readmission rates
compared with the control group (23% vs 29%), with a 50% risk
reduction after adjustment for clinical diagnoses.35
In Hong Kong, private insurance is not mandatory and pri-
mary care is largely fee-for-service. Many patients with chronic
diseases such as diabetes attended the emergency depart-
ment for various ailments followed by observations in short-
stay wards before discharge or triage to long-stay wards. In this
hospital-clinic based population, 17% had cardiovascular-
renal complications and 80% of hospitalized patients had co-
morbidities with high levels of emotional distress. During the
study period, 20% in the JADE + PEARL group and 26% in the
JADE group required at least 1 admission, which might be due
to the lack of community support or access to regular family
physicians. Whether peer support might reduce hospitaliza-
tion, especially in vulnerable patients with comorbidities and
emotional distress, requires further study.
In an exploratory analysis, we observed benefits of peer
support in the 20% of patients with elevated levels of emo-
tional distress (DASS-21 score ≥17). In these patients, the hos-
pitalization rate was 48% in the JADE and 17% in the
JADE + PEARL groups. In these distressed patients with high
rates of nonadherence and hospitalizations (data not shown),
peer support reduced nonadherence and negative emotions,
which might have contributed to the lower hospitalization
rates. Other researchers had reported greater benefits of peer
support on HbA1c level in the patients with T2DM with poor
treatment compliance.36 In a 6-month study, patients with de-
pression who received 10 telephone calls, with a mean dura-
tion of 26 minutes, had reduced depressive symptoms com-
pared with the control group.31 Among US Medicaid enrollees,
lack of regular care, low levels of family and social support, and
mental illness were associated with frequent hospitalizations.37
In a subsequent integrated postdischarge care program with
data sharing and communication among team members, hos-
pitalizations were reduced by 37.5%, with a cost reduction of
US $16 383 per patient over 12 months.38 In patients receiving
integrated care with empowerment and decision support, peer
support may confer additional benefits only in high-risk pa-
tients such as those with comorbidities, noncompliance, emo-
tional distress, and associated disproportionate hospital and
emergency care.
We used validated methods to evaluate pragmatic and
multidimensional approaches to improve quality of care.39
In this multicomponent project that builds on 2 decades of
quality improvement initiatives, we have rigorously tested
the added effects of peer support in patients with T2DM
receiving integrated care and found that peer support did
not improve cardiometabolic risks or psychological health.
While our exploratory analysis suggested that patients with
psychological distress may benefit most from peer support,
these results will need external replication. There are ongo-
ing peer support activities in the participating centers, but
none of them had structured programs as described herein.
Peer supporters were not aware of the control group, making
contamination unlikely.
Conclusions
In patients with T2DM receiving integrated care through a web-
based multicomponent quality improvement program, peer
support did not improve cardiometabolic control and psycho-
logical well-being. Whether such peer support could benefit
high-risk patients with emotional distress requires further
study.
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